In Situ Thrombosis
In 1860, Virchow postulated that thrombus can form as a result of vessel injury, disturbance of blood flow and hypercoagulability. A spectrum of diseases can be associated with one or all three of these precipitating factors, with the aftereffect of in situ thrombosis in the pulmonary vasculature. The criteria for in situ thrombus include (1) the presence of thrombus at the site of vessel injury and/or site of disturbance of blood flow and (2) the absence of other pulmonary vessel thrombi remote from the site of vessel abnormality. This chapter illustrates examples of in situ thrombosis of the pulmonary arteries and veins.
Tumor-Related Pulmonary Artery Thrombosis
In patients who have lung cancer, all three factors may be present: vessel injury from local tumor invasion, disturbance of blood flow, and hypercoagulability (Fig. 5.1).
The differentiation between direct tumor growth along a vessel lumen and in situ thrombosis may be impossible based on imaging at one time point. Pathologically, the two often coexist.
Radiotherapy-Related Pulmonary Artery Thrombosis
The early effects of radiation on endothelial cells are characterized by swelling and sloughing.
Such vessel-wall injury can lead to in situ thrombosis (Fig. 5.2).
Pulmonary Artery Stump Thrombosis
In patients who have undergone resection for lung cancer, all three prothrombotic factors are present: vessel injury, disturbance of blood flow, and hypercoagulability.
The prevalence is 12%.
There is a relationship between stump length and the development of in situ thrombosis.
The shape of the thrombus can be convex (Fig. 5.3) or concave (Fig. 5.4).
Stump thrombosis appears to have a benign natural history.